Uma udinga ukulahlekelwa isisindo, ungase ufune ukufunda okwengeziwe nge-Saxenda, i -ject injection injectable drug. Umkhiqizo awulungile ukuthi ucwaningo lwama-everyoneut lubonise ukuthi ukujola isisindo sokulahlekelwa kwesisindo kungakusiza ukuba ufinyelele futhi ulondoloze isisindo esinempilo.
Kuyini iSaxenda?
I-Saxenda (umjovo we-liraglutide [i-rNNA origin] umuthi osiza umzimba wakho uzizwe ugcwele ngokushesha ngemuva kokudla.
Lokhu kungakusiza ukuba udle konke okuncane. Imithi ifika epeni eligcwalisiwe futhi ifakwe emzimbeni wakho kanye nosuku ngalunye, nganoma isiphi isikhathi sosuku. Uma uthatha i-Saxenda, uzosebenzisana nodokotela wakho ukuze ufinyelele umthamo ofanele, kufika ku-3 mg.
I-Saxenda ingasetshenziswa iziguli ezinamafutha amaningi (ane-BMI engama-30 noma ngaphezulu) noma ngeziguli ezine-BMI ezinama-27 noma ngaphezulu nesimo sezokwelapha ezihlobene nesisindo esinjenge-type 2 yesifo sikashukela, i-cholesterol ephakeme noma umfutho wegazi ophezulu. Iziguli ezithatha i-Saxenda kufanele nazo zikulungele ukuzibophezela ekushintsheni indlela yokuphila, kuhlanganise nokudla okunempilo nokuzivocavoca .
Ezinye iziguli akufanele zithathe iSaxenda. Lezi zihlanganisa iziguli ezikhulelwe, iziguli eziye zabhekana nokuhlasela okungathí sina ku-liraglutide noma noma yiziphi izingxenye zayo nalabo abanomlando womuntu siqu noma womndeni we-medullary carcinoma ye-thyroid (MTC) noma i-endocrine neoplasia syndrome type 2 (MEN 2).
Kumele futhi ugweme ukuthatha i-Saxenda uma uthatha enye i-GLP-1 receptor agonist noma uma usebenzisa i-insulin.
I-Saxenda nomunye umuthi ovamile obizwa ngokuthi i-Victoza (okwenzelwe ukwelashwa uhlobo lwesifo sikashukela) unesithako esisebenzayo esifanayo, i-liraglutide. I-Victoza inikeza umthamo ophansi we-liraglutide.
Le mithi emibili akufanele isetshenziswe ndawonye.
Kufanele ukhulume nodokotela wakho ukuqinisekisa ukuthi i-Saxenda iphephile kuwe. Umhlinzeki wakho wokunakekelwa kwempilo uzohlola umlando wakho wezempilo kanye nemibandela yakho yezokwelapha ukunquma ukuthi ungayisebenzisa yini imithi futhi uma kungenzeka ukuthuthukisa impilo yakho.
Ingabe Isisindo Sokulahlekelwa Isisindo Sizosiza Sinciphise Isisindo?
Kuhlale kunengqondo ukulinganisa ukuthi ungakanani ulahlekelwa yimuphi umuthi. Ukulahleka kwesisindo sakho kanye ne-liraglutide kuzoxhomeka ezintweni eziningana okubandakanya ukuthi ubekezelela kangakanani imithi nokuthi ubambelela kanjani ohlelweni oluphansi lokudla nokuzivocavoca. Kodwa ucwaningo lwamuva luzokunika isilinganiso sokuthi isisindo siphelelwa yiziphi iziguli ezithatha i-Saxenda.
Ezilingo zomtholampilo, iziguli ezakhetha lolu hlobo lomjovo wokulahlekelwa isisindo zalahlekelwa isisindo esingaphezu kwalezi ziguli ezithatha i-placebo. Iziguli ezacwaningwa zathatha imithi yonyaka futhi zathola ukululekwa ukugqugquzela ukudla nokuzivocavoca. Ekupheleni kwesifundo, amaphesenti angama-64 weziguli ezingenaso isifo sikashukela alahlekelwe okungenani amaphesenti angu-5 esisindo somzimba, kuyilapho amaphesenti angu-34 kuphela alabo abathatha indawo ye-placebo afinyelela lowo mgomo. Kulabo abagulayo abanesifo sikashukela, amaphesenti angama-49 weziguli eziphathwa nge-Saxenda alahlekelwe okungenani amaphesenti angu-5 wesisindo somzimba wabo uma kuqhathaniswa namaphesenti angu-16 eziguli eziphathwa nge-placebo.
Ngakho lokho kusho ukuthini kuwe? Uma okwamanje ulinganisa amakhilogremu angu-250 futhi uthatha i-Saxenda, unamathele ekudleni okuphansi kwekhalori futhi usebenzise njalo, kungenzeka ukuthi ulahlekelwa amakhilogremu angu-12,5 noma ngaphezulu. Kodwa khumbula ukuthi uzodinga ukuqhubeka nendlela yakho yokuphila enempilo ukuze ugcine isisindo sibe ngcono.
Abenzi balesi sidakamizwa sokulahlekelwa kwesisindo esijoqayo banikeza uhlelo lokusekela olubizwa nge-SaxendaCare. Iziguli ezibhalisa kulolu hlelo zithola ulwazi oluthe xaxa, ukwesekwa kwe-coaching, ama-imeyili onke masonto nokusekelwa kokulondoloza ukusiza ukuba kufinyelele imigomo yabo yesisindo esinempilo.
Ama-Effect Side Effects
Ekuvivinyweni komtholampilo, imiphumela emibi kakhulu ebonakalayo ezigulweni eziphathwe nge-Saxenda kwakuyisicashu, ishukela ephansi yegazi, isifo sohudo, ukugcoba, ukuhlanza, ukukhanda ikhanda, ukwehlisa isifiso, ukucindezeleka, ukukhathala, isizungu, nobuhlungu besisu.
Ngaphezu kwalokho, ezinye iziguli ezithatha uSaxenda zabika imiphumela embi kakhulu ehlanganisa ukuhlasela kwe-pancreatitis, isifo se-gallbladder, ukukhubazeka komzimba, nokucabanga okuzibulala. I-Saxenda ingabuye iphakamise isilinganiso senhliziyo. Kumele uyeke ukuwuthatha uma ubona ukwanda kwenani lakho lokuphumula lenhliziyo eliqhubekayo ngokuhamba kwesikhathi.
Izindleko zeSaxenda Zingakanani?
Izintengo ze-Saxenda ziyahlukahluka, kodwa izindleko ze-liraglutide zingasebenzisa i-$ 30 ngosuku noma ngaphezulu. Izindleko zenyanga zonke ze-Saxenda ngokuvamile zilinganiswa ukuthi ziyizigidi ezingu-1,200, kodwa amanani ahluka kuye ngokuthi ikhemisi yakho nendawo
Noma kunjalo, ukwelashwa kwakho kungase kuhlanganiswe inkampani yakho yomshuwalense. Ungashayela umhlinzeki wakho womshuwalense ukuze ubone ukuthi imithi ihlanganiswe kanjani ohlelweni lwakho, noma ungavakashela iwebhusayithi ye-Saxenda futhi usebenzise ithuluzi lakho le-copay ukuze uthole isilinganiso.
Ungase futhi ukwazi ukuzuza ku-Saxenda Savings Card. Ngokusho kolwazi lokuphromotha, abanye abasebenzisi bakwazi ukukhokha okungenani u-$ 30 noma balondoloze kufika ku-$ 200 ngomuthi odokotela. Khumbula, Nokho, ukuthi kukhona inzuzo enkulu ye $ 200 ngomuthi odokotela kanye nezinzuzo ezingu-12 njalo ngonyaka. Qinisekisa ukuthi ukhuluma nodokotela wakho mayelana nokuthi uzodinga isikhathi esingakanani ukuba ube semithi ukuze ukwazi ukubala izindleko zangempela zokwelashwa esikhathini eside.
Imithombo:
Idokhumenti ye-FDA Briefing. "Idokhumenti ye-FDA Briefing NDA 206321 I-Liraglutide, 3mg." Ngo-September 11, 2014.
I-FDA News Release. "I-FDA ivumela izidakamizwa zokulawulwa kwesisindo sikaSaintenda." Ukuphathwa Kwezokudla Nezidakamizwa zase-US. Kufinyelelwe: Mashi 2, 2015. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm
Umhlahlandlela wamayeza we-Saxenda. I-Novo Nordisk. Kufinyelelwe: Mashi 2, 2015. http://www.novo-pi.com/saxenda_med.pdf